Aristo Bio-Tech And Lifescience Limited — Others, 23-08-2025: Copy of Newspaper Publication

Aristo Bio-Tech and Lifescience has issued an addendum to its upcoming 20th Annual General Meeting, scheduled for September 08. This addendum adds three special business items for shareholder approval. These items involve revising the remuneration payable to Mr. Narendra Singh Barhat (Chairman and Managing Director), Mrs. Kusum Narendra Singh Barhat (Executive Director), and Mr. Ketankumar Harkantbhai Joshi (Whole Time Director). The Nomination & Remuneration Committee had proposed these revisions. Shareholders can utilize remote e-voting for these resolutions from September 5 to September 7. This update directly impacts executive compensation and requires investor attention.